Results 191 to 200 of about 31,202,450 (314)

The role of factor V in trauma-induced coagulopathy: an observational and experimental study. [PDF]

Res Pract Thromb Haemost
Sloos PH, Dujardin RWG, Meijers JCM, Gaarder C, Davenport R, Stanworth S, Johansson PI, Stensballe J, Maegele M, Juffermans NP, Kleinveld DJB.   +10 more
europepmc   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Radioimmunoassay of factor V in human plasma and platelets.

Blood, 1982
P. Tracy, L. Eide, E. Bowie, K. Mann
semanticscholar   +1 more source

Combined deficiency of factor V and factor VIII in a pediatric patient: a case report. [PDF]

J Med Case Rep
Bendarkawi Y, Mamad H, Berchane Z, Benkirane S, Masrar A.   +4 more
europepmc   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.

Journal of Clinical Investigation, 1980
R. Marlar, J. Griffin
semanticscholar   +1 more source

Supercharged Hypercoagulability: A Case of Heparin-Induced Thrombocytopenia With Thrombosis in a Patient With Double Heterozygous Factor V Leiden and Prothrombin Mutations. [PDF]

Case Rep Hematol
Okabe Y, Rodriguez JI, Edmunds J, Dhliwayo NL.   +3 more
europepmc   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Isolation and study of an acquired inhibitor of human coagulation factor V.

Journal of Clinical Investigation, 1986
M. Nesheim, W. Nichols, Thérèse, L. Cole, J. Houston, Richard B. Schenk, K. Mann, J. E., Walter Bowie   +8 more
semanticscholar   +1 more source

Recurrent arterial and venous thrombosis in a 39-year-old male with Factor V Leiden syndrome and aneurysmal disease: a case report and review of the literature. [PDF]

Thromb J
Mohammed A, Abdallah HO, Kharouf A, Hamed A.   +3 more
europepmc   +1 more source